{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/JSPR",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Jasper Therapeutics, Inc. (NASDAQ: JSPR) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Jasper Therapeutics, Inc., listed on NASDAQ under ticker JSPR, ISIN US4718712023. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 70 filings in the window 2025-11-08 to 2026-11-08, across 49 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-04, four days before the record date of 2026-11-08, and is a corporate_news filing. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4,359 issuers. In the sector the median cadence gap is 5.5 days, the median filings count is 65.5, and the median latency is 4.0 days across 176 issuers. The issuer's 70 filings are above the NASDAQ median of 52 and above the sector median of 65.5. Its cadence gap of 4.0 days is below the NASDAQ median of 6.0 days and below the sector median of 5.5 days. Its latency of 4 days is below the NASDAQ median of 5.0 days and equal to the sector median of 4.0 days. By type the window holds 2 ad_hoc, 8 agm_egm, 10 corporate_news, 3 director_change, 15 directors_dealings, 2 halt_suspension, 1 prospectus, 18 regulatory_filing, 9 results, and 2 takeover filings.\n\n## Auditor\n\nThe auditor of record is PricewaterhouseCoopers LLP, located in San Jose, California. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds one lifecycle line: a delisting dated 2026-09-24. No listing, name change or segment move is on the record, and the domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read. The count is 0.\n\n## Open research\n\nNo openly published research notes were found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001788028.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/JSPR (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1788028/000121390026036426/ea0282128-10k_jasper.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/JSPR (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1788028/000121390026036426/ea0282128-10k_jasper.htm",
    "state": "sourced",
    "value": "PricewaterhouseCoopers LLP"
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1788028/000121390026036426/ea0282128-10k_jasper.htm",
    "state": "sourced",
    "value": "238"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1788028/000121390026036426/ea0282128-10k_jasper.htm",
    "state": "sourced",
    "value": "San\nJose, California"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/JSPR",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 176,
     "median_cadence_gap_days": 5.5,
     "median_filings": 65.5,
     "median_latency_days": 4,
     "name": "2836 Biological Products, (No Diagnostic Substances)"
    }
   },
   "by_type": {
    "ad_hoc": 2,
    "agm_egm": 8,
    "corporate_news": 10,
    "director_change": 3,
    "directors_dealings": 15,
    "halt_suspension": 2,
    "prospectus": 1,
    "regulatory_filing": 18,
    "results": 9,
    "takeover": 2
   },
   "cadence_median_gap_days": 4,
   "filing_days": 49,
   "filings": 70,
   "latency_days": 4,
   "latest": [
    {
     "category": "8-K",
     "date": "2026-11-04",
     "source": "https://www.sec.gov/Archives/edgar/data/1788028/000121390026115751/ea0309978-8k_jasper.htm",
     "title": "8-K — CURRENT REPORT (items 3.03,5.03,7.01,9.01)",
     "type": "corporate_news"
    },
    {
     "category": "SCHEDULE 13G",
     "date": "2026-10-28",
     "source": "https://www.sec.gov/Archives/edgar/data/1788028/000007085826000538/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G",
     "type": "regulatory_filing"
    },
    {
     "category": "SC TO-I/A",
     "date": "2026-10-23",
     "source": "https://www.sec.gov/Archives/edgar/data/1788028/000121390026112090/ea0309476-sctoia1_jasper.htm",
     "title": "SC TO-I/A — AMENDMENT NO. 1 TO FORM SC TO-I",
     "type": "takeover"
    },
    {
     "category": "DEF 14A",
     "date": "2026-10-19",
     "source": "https://www.sec.gov/Archives/edgar/data/1788028/000121390026110751/ea0307636-02.htm",
     "title": "DEF 14A — PROXY STATEMENT",
     "type": "agm_egm"
    },
    {
     "category": "8-K",
     "date": "2026-10-15",
     "source": "https://www.sec.gov/Archives/edgar/data/1788028/000121390026109587/ea0308657-8k_jasper.htm",
     "title": "8-K — CURRENT REPORT (items 8.01,9.01)",
     "type": "corporate_news"
    }
   ],
   "latest_filing_date": "2026-11-04",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/JSPR",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-14",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US4718712023"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001788028.json",
    "state": "sourced",
    "value": "United States — Delaware"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-DE",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001788028.json",
    "state": "sourced",
    "value": "Jasper Therapeutics, Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001788028.json",
    "state": "sourced",
    "value": "2836 Biological Products, (No Diagnostic Substances)"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001788028.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "JSPR"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [
    {
     "date": "2026-09-24",
     "source": "https://www.sec.gov/Archives/edgar/data/1788028/000135445726000914/xslF25X02/primary_doc.xml",
     "title": "25-NSE"
    }
   ],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:9875571e422cbfb5ed03200c6a25a25ad826773947721253c495375cbbd95acd",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/JSPR",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:9875571e422cbfb5ed03200c6a25a25ad826773947721253c495375cbbd95acd",
 "path": "/us/NASDAQ/JSPR",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Jasper Therapeutics, Inc., listed on NASDAQ under ticker JSPR, ISIN US4718712023. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 70 filings in the window 2025-11-08 to 2026-11-08, across 49 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-04, four days before the record date of 2026-11-08, and is a corporate_news filing. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4,359 issuers. In the sector the median cadence gap is 5.5 days, the median filings count is 65.5, and the median latency is 4.0 days across 176 issuers. The issuer's 70 filings are above the NASDAQ median of 52 and above the sector median of 65.5. Its cadence gap of 4.0 days is below the NASDAQ median of 6.0 days and below the sector median of 5.5 days. Its latency of 4 days is below the NASDAQ median of 5.0 days and equal to the sector median of 4.0 days. By type the window holds 2 ad_hoc, 8 agm_egm, 10 corporate_news, 3 director_change, 15 directors_dealings, 2 halt_suspension, 1 prospectus, 18 regulatory_filing, 9 results, and 2 takeover filings.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is PricewaterhouseCoopers LLP, located in San Jose, California. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds one lifecycle line: a delisting dated 2026-09-24. No listing, name change or segment move is on the record, and the domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001788028.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/JSPR"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1788028/000121390026036426/ea0282128-10k_jasper.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/JSPR"
  }
 ],
 "title": "Jasper Therapeutics, Inc. (JSPR) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}